JPRN-UMIN000011453已完成未知
Prospective study of chemoradiotherapy with gemcitabine and S-1 for borderline resectable or unresectable pancreatic cancer - Prospective study of chemoradiotherapy with gemcitabine and S-1 for borderline resectable or unresectable pancreatic cancer
Multicenter Clinical Study Group of Osaka0 个研究点目标入组 50 人开始时间: 2013年8月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
unpublished
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Resectable pancreatic cancer (2) Presence or past history of Interstitial pneumonia or pulmonary fibrosis or possible (3) Watery diarrhea (4) Active infections (excluding viral hepatitis) (5) Severe cardiac disorder, renal disorder, liver disorder, ulcer with bleeding, intestinal tract paralysis, uncontrollable diabetes mellitus (6) Presence of pleural effusion or ascites requiring drainage (7) Presence of metastasis in central nervous system (8) Active double cancer except carcinoma in situ or intramucosal cancer (synchronous double cancer or asynchronous double cancer with disease-free duration to be within 3 years) (9) Treatment with phenytoin, potassium warfarin or flucytosine (10) Pregnant females or nursing mothers who can not stop lactation. Patients or partners, who don't attempt to doing contraception during the study period. (11) Severe mental disorder (12) Severe drug hypersensitivity (13) As determined by the principal investigator or the sub-investigator the subject is not adequate to participate in the trial
研究者
相似试验
已完成
1 期
A phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic adenocarcinomanresectable locally advanced pancreatic adenocarcinomaJPRN-UMIN000012254Osaka Medical Center for Cancer and Cardiovascular Diseases Division of Hepatobiliary and Pancreatic Oncology54
已完成
不适用
Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancerunresectable locally advanced pancreatic cancerJPRN-UMIN000020475Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine24
已完成
1 期
preoperative gemcitabine based chemoradiation therapy for resectable and borderline resectable pancreatic cancer phase1 studyresectable and borderline resectable pancreatic cancerJPRN-UMIN000020977fukushima medical university30
已完成
1 期
A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic CancerPancreatic CancerNCT02272738Osaka Medical Center for Cancer and Cardiovascular Diseases54
招募中
不适用
Gemcitabine en radiotherapie in combinatie met panitumumab bij patiënten met niet uitgezaaide, inoperabele alvleesklierkanker.Pancreatic cancerPancreas cancerAlvleesklierkankerPancreaskankerNL-OMON25995Prof. dr. H.M.W. Verheul, M.D., Ph.D.Head Department of Medical OncologyVU University Medical CenterDe Boelelaan 11171081 HV AmsterdamPhone: +31-20-4444321/300Fax: + 31-20-4444079Email: h.verheul@vumc.nl63